Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Evaluation of the Safety and Efficacy of a Combination of Niacin ER and Simvastatin in Patients With Dyslipidemia (OCEANS)

NCT00080275 is registered in ClinicalTrials.gov with Kos Pharmaceuticals as lead sponsor.

NCT NCT00080275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00080275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Evaluation of the Safety and Efficacy of a Combination of Niacin ER and Simvastatin in Patients With Dyslipidemia (OCEANS)
Lead sponsor
Kos Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2004
Completion date
Not reported
Enrollment
600
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia